These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 93578)
1. Epstein-Barr virus-specific antibody-dependent cellular cytotoxicity in patients with Burkitt's lymphoma. Pearson GR; Qualtiere LF; Klein G; Norin T; Bal IS Int J Cancer; 1979 Oct; 24(4):402-6. PubMed ID: 93578 [TBL] [Abstract][Full Text] [Related]
2. Antibody-dependent cell-mediated cytotoxicity against Epstein-Barr virus membrane antigen in African Burkitt's lymphoma. Granlund DJ; Nkrumah F; Perkins IV; Biggar RJ; Levine PH; Fuccillo DA Int J Cancer; 1979 Nov; 24(5):567-71. PubMed ID: 231015 [TBL] [Abstract][Full Text] [Related]
3. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined antigens. III. Reactivity in sera from patients with Burkitt's lymphoma in relation to tumour development. Jondal M; Gunven P Clin Exp Immunol; 1977 Jul; 29(1):11-5. PubMed ID: 70292 [TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-induced membrane antigens: immunochemical characterization of Triton X-100 solubilized viral membrane antigens from EBV-superinfected Raji cells. Qualtiere LF; Pearson GR Int J Cancer; 1979 Jun; 23(6):808-17. PubMed ID: 89099 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus gp350-specific antibody titers and antibody-dependent cellular cytotoxic effector function in different groups of patients: a study using cloned gp350-expressing transfected human T cell targets. Khyatti M; Stefanescu I; Blagdon M; Menezes J J Infect Dis; 1994 Dec; 170(6):1439-47. PubMed ID: 7995983 [TBL] [Abstract][Full Text] [Related]
7. Burkitt's lymphoma - a human tumor model system for immunological studies. Gunvén P Biochim Biophys Acta; 1975 Dec; 417(3-4):187-210. PubMed ID: 175835 [TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus-specific IgA serum antibodies as an outstanding feature of nasopharyngeal carcinoma. Henle G; Henle W Int J Cancer; 1976 Jan; 17(1):1-7. PubMed ID: 175020 [TBL] [Abstract][Full Text] [Related]
9. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma. Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of Epstein-Barr virus (EBV) release from the P3HR-1 Burkitt's lymphoma cell line by a monoclonal antibody against a 200,000 dalton EBV membrane antigen. Sairenji T; Reisert PS; Spiro RC; Connolly T; Humphreys RE J Exp Med; 1985 May; 161(5):1097-111. PubMed ID: 2580934 [TBL] [Abstract][Full Text] [Related]
11. Epstein-Barr virus (EBV) glycoprotein gp350 expressed on transfected cells resistant to natural killer cell activity serves as a target antigen for EBV-specific antibody-dependent cellular cytotoxicity. Khyatti M; Patel PC; Stefanescu I; Menezes J J Virol; 1991 Feb; 65(2):996-1001. PubMed ID: 1846213 [TBL] [Abstract][Full Text] [Related]
12. Burkitt's lymphoma: its clinical course in relation to immunologic reactivities to Epstein-Barr virus and tumor-related antigens. Nkrumah F; Henle W; Henle G; Herberman R; Perkins V; Depue R J Natl Cancer Inst; 1976 Nov; 57(5):1051-6. PubMed ID: 187787 [TBL] [Abstract][Full Text] [Related]
13. Antibody and antibody-dependent cellular cytotoxicity responses against the BamHI A rightward open-reading frame-1 protein of Epstein-Barr virus (EBV) in EBV-associated disorders. Tanner JE; Wei MX; Alfieri C; Ahmad A; Taylor P; Ooka T; Menezes J J Infect Dis; 1997 Jan; 175(1):38-46. PubMed ID: 8985194 [TBL] [Abstract][Full Text] [Related]
14. Immune escape by Epstein-Barr virus (EBV) carrying Burkitt's lymphoma: in vitro reconstitution of sensitivity to EBV-specific cytotoxic T cells. Masucci MG; Zhang QJ; Gavioli R; De Campos-Lima PO; Murray RJ; Brooks J; Griffin H; Ploegh H; Rickinson AB Int Immunol; 1992 Nov; 4(11):1283-92. PubMed ID: 1282031 [TBL] [Abstract][Full Text] [Related]
15. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line. Gregory CD; Rowe M; Rickinson AB J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133 [TBL] [Abstract][Full Text] [Related]
16. Antibodies in human sera against the Epstein-Barr virus encoded latent membrane protein (LMP). Sulitzeanu D; Szigeti R; Hatzubai A; Dillner J; Hammarskjöld ML; Klein G; Klein E Immunol Lett; 1988 Aug; 18(4):301-6. PubMed ID: 2846438 [TBL] [Abstract][Full Text] [Related]
17. A cluster of Epstein-Barr-virus-associated American Burkitt's lymphoma. Judson SC; Henle W; Henle G N Engl J Med; 1977 Sep; 297(9):464-8. PubMed ID: 196197 [TBL] [Abstract][Full Text] [Related]
18. Antibodies to Epstein-Barr viral capsid and early antigens associated with Burkitt's lymphoma and lymphoblastic lymphosarcoma in Israel. Gotleib-Stematsky T; Ramot B; Vonsover B; Aghai E; Kende G; Ninio M; Modan M J Natl Cancer Inst; 1976 Apr; 56(4):721-3. PubMed ID: 233958 [TBL] [Abstract][Full Text] [Related]
19. Antibodies to Epstein-Barr virus associated antigens in Burkitt's lymphoma. Gunvén P; Klein G; Henle G; Henle W; Clifford P; Singh S Bibl Haematol; 1973; 39():813-7. PubMed ID: 4360196 [No Abstract] [Full Text] [Related]
20. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients. Gunvén P; Klein G; Henle G; Henle W; Clifford P Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656 [No Abstract] [Full Text] [Related] [Next] [New Search]